Latest Posts

Tag: ARCH Venture Partners

Initial investment $217M at Denali Therapeutics

Having received an initial investment commitment of 217 million dollars, Denali Therapeutics, a new biotechnology company focused on developing effective therapies for neurodegenerative diseases launched its services. Among the founding investors of the company are Fidelity Biosciences, ARCH Venture Partners, Flagship Ventures and the Alaska Permanent Fund. Denali Therapeutics is based on the collaboration of […]

Keep Reading
Go to TOP